| An Open-Label Treatment Protocol to Provide Continued Elvucitabine Treatment (NCT00675844) | Alexion Pharmaceuticals, Inc. | 2008-05-01 |
| Second-line Therapy Antiretroviral in Patients Who Failed Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI) - Based Regimens (NCT00627055) | The HIV Netherlands Australia Thailand Research Collaboration | 2008-05-01 |
| Safety and Efficacy Study of MPC-4326 for Treatment of Patients With HIV-1 Infection. (NCT00967187) | Myrexis Inc. | 2008-05-01 |
| Follow-up on the HIGH: Low Study - the Longterm Effects of Growth Hormone (NCT00662181) | Hvidovre University Hospital | 2008-05-01 |
| Study of Viral Load Decay Rates in HIV Infected Participants Starting Treatment With Raltegravir (RAL) and Emtricitabine/Tenofovir Disoproxil Fumarate (TDF) (NCT00660972) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-05-01 |
| Drug Treatment Combined With Drug and Risk Reduction Counseling to Prevent of HIV Infection and Death Among Injection Drug Users (NCT00270257) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-05-01 |
| Age-17 Follow-up of Home Visiting Intervention (NCT00708695) | University of Colorado, Denver | 2008-05-01 |
| Pilot Study With Isentress (Raltegravir) and Epzicom (Abacavir/Lamivudine) in Treatment Naive HIV-Infected Subjects (NCT00740064) | Denver Infectious Disease Consultants, PLLC | 2008-05-01 |
| Enhancing Communication and HIV Outcomes (NCT00675610) | Johns Hopkins University | 2008-05-01 |
| Incidence of Oral Candidiasis, Prevalence of C. Dubliniensis in HIV Patients and In-vitro Azole Susceptibility (NCT00692783) | University of Florida | 2008-05-01 |
| Maraviroc 300 mg Twice Daily in HIV Negative Male Volunteers (NCT00771823) | St Stephens Aids Trust | 2008-05-01 |
| A Long Term Safety Study of Apricitabine in HIV-infected Patients (NCT00686270) | Avexa | 2008-05-01 |
| HIV Treatment-Readiness Measure (HTRM) Validation (NCT00686049) | University of North Carolina, Chapel Hill | 2008-05-01 |
| Intensive Viral Dynamics Substudy of A5248 (NCT00852618) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-05-01 |
| The Influence of Raltegravir on Pravastatin Pharmacokinetics(GRAPPA) (NCT00665717) | Radboud University Medical Center | 2008-05-01 |
| Nevirapine Drug Levels in HIV Positive Patients Also Receiving Rifampicin for Tuberculosis (NCT00617643) | Makerere University | 2008-05-01 |
| TMC278-TiDP6-C209: A Clinical Trial in Treatment Naive HIV-1 Patients Comparing TMC278 to Efavirenz in Combination With Tenofovir + Emtricitabine. (NCT00540449) | Tibotec Pharmaceuticals, Ireland | 2008-05-01 |
| Innate Immunity in HIV Positive Patients Co-infected With Hepatitis C Virus (HCV) or Hepatitis B Virus (HBV) (NCT00662194) | Bayside Health | 2008-04-01 |
| Efficacy of Influenza Vaccine in HIV Infected Adults (NCT00757900) | University of Witwatersrand, South Africa | 2008-04-01 |
| Effectiveness of Community-Level Behavioral and Biomedical Interventions for Reducing HIV/STIs in Men in Peru (NCT00670163) | University of California, Los Angeles | 2008-04-01 |
| A Surveillance Program for the Detection of Hepatitis B Virus (HBV) Resistance to Tenofovir in HIV-HBV co-Infected Patients (NCT00660361) | Bayside Health | 2008-04-01 |
| Entecavir Intensification for Persistent HBV Viremia in HIV-HBV Infection (NCT00662545) | University of California, San Francisco | 2008-04-01 |
| The Detection of Drug-Resistant HIV-1 in Taiwan (NCT00690001) | National Taiwan University Hospital | 2008-04-01 |
| Observational Study on Anti-Tat Immune Response in HIV-1-infected Asymptomatic Adult Subjects (NCT01029548) | Barbara Ensoli, MD | 2008-04-01 |
| A Controlled Study of the Safety and Efficacy of Lessertia Frutescens in HIV-infected South African Adults (NCT00549523) | University of Missouri-Columbia | 2008-04-01 |
| Surveillance and Medical Help for HIV-infected Intravenous Drug Users in and Out of Prison (NCT00739258) | Kaohsiung Medical University Chung-Ho Memorial Hospital | 2008-04-01 |
| Minocycline for HIV+ Cognitive Impairment in Uganda (NCT00855062) | Johns Hopkins University | 2008-04-01 |
| Raltegravir Augmentation on Persistent Central Nervous System (CNS) Immunoactivation in Treated HIV-1 Patients (NCT00672932) | University of California, San Francisco | 2008-04-01 |
| A 72-week Randomized Clinical Trial Comparing the Safety and Efficacy of Three Initial Antiretroviral Regimens -GPO-VIR S (d4T/3TC/NVP) for 24 Weeks Followed by GPO-VIR Z (AZT/3TC/NVP) vs GPO-VIR Z vs TDF/FTC/NVP (NCT00669487) | SEARCH Research Foundation | 2008-04-01 |
| Effectiveness of Rosuvastatin at Preventing the Progression of Atherosclerosis in HIV Positive Patients (NCT00673582) | University of British Columbia | 2008-04-01 |
| Interaction of Buprenorphine With HIV Medications and Tuberculosis Medications (NCT00877591) | University of California, San Francisco | 2008-04-01 |
| HSV-2 Suppression to Reduce Maternal HIV-1 RNA Levels During Pregnancy and Breastfeeding (NCT00530777) | University of Washington | 2008-04-01 |
| QoL and Adherence to One-pill Once-a-day HAART (NCT00990600) | A.O. Ospedale Papa Giovanni XXIII | 2008-04-01 |
| ONCE - Only Nocturnal Combination Evaluation of Antiretroviral-Experienced HIV 1 Infected Subjects Switching to Atripla (NCT00615745) | Gilead Sciences | 2008-04-01 |
| Integrated Treatment of Marijuana Abuse for HIV+ Youth (NCT00683488) | University of North Carolina, Chapel Hill | 2008-04-01 |
| Raltegravir and Atazanavir Replacing Current Suppressive Treatment Because of Side Effects in Current Treatment (NCT00751153) | Peter J. Ruane, M.D., Inc. | 2008-03-01 |
| Effect of Vicriviroc on HIV Ribonucleic Acid (RNA) Levels in Cerebrospinal Fluid (Study P05241) (NCT00632073) | Merck Sharp & Dohme LLC | 2008-03-01 |
| Treatment of Acute Hepatitis C Virus in HIV Co-Infection (NCT00845676) | University of California, San Francisco | 2008-03-01 |
| Impact of Antiretroviral Therapy on Cardiac Biomarkers (NCT00641888) | University of California, Davis | 2008-03-01 |
| Feasibility and Pilot Efficacy of Flash-heated Breast Milk to Reduce Maternal-to-Child-Transmission of HIV in Tanzania (NCT00523510) | University of California, Davis | 2008-03-01 |
| Adjusting Antiretroviral Therapy Dosage Using Therapeutic Drug Monitoring (NCT00836212) | University Hospital, Geneva | 2008-03-01 |
| Study of PRO 140 by Subcutaneous Administration in Adult Subjects With HIV -1 Infection (NCT00642707) | CytoDyn, Inc. | 2008-03-01 |
| Evaluation of the DPP HIV 1/2 Test and the HIV 1/2 Stat Pak Test Using Oral Fluid (NCT00636220) | Chembio Diagnostic Systems, Inc. | 2008-03-01 |
| Prevention of Depression in HIV/HCV Co-infected Substance Abuse Patients (NCT00655226) | Icahn School of Medicine at Mount Sinai | 2008-03-01 |
| ROCKET I - Randomized Open Label Switch for Cholesterol Elevation on Kivexa Evaluation Trial (NCT00615810) | Gilead Sciences | 2008-03-01 |
| Trial of Zinc and HIV Progression in Children (NCT00446758) | Harvard School of Public Health (HSPH) | 2008-03-01 |
| BRAVO: Background Regimen of Raltegravir on Virologic Outcome (NCT00751530) | Community Research Initiative of New England | 2008-03-01 |
| Social-Psychological Intervention to Improve Adherence to HAART (NCT00716040) | University of Sao Paulo | 2008-03-01 |
| Sex, Aging and Antiretroviral Pharmacokinetics (NCT00666055) | Kristine Patterson, MD | 2008-03-01 |
| Early Antiretroviral Treatment and/or Early Isoniazid Prophylaxis Against Tuberculosis in HIV-infected Adults (ANRS 12136 TEMPRANO) (NCT00495651) | French National Agency for Research on AIDS and Viral Hepatitis | 2008-03-01 |
| Raltegravir Intensification in HIV-infected Patients (NCT00631449) | University of California, San Francisco | 2008-02-01 |
| Integrating Targeted MedlinePlus Health Prescriptions Into Clinic Practice Workflow (NCT00634608) | University of Missouri-Columbia | 2008-02-01 |
| Genetic Predictors of Variability in the Drug-drug Interaction Between Darunavir/Ritonavir and Pravastatin (NCT00630734) | University of Colorado, Denver | 2008-02-01 |
| Phase II Study of AGS-004 as an Immunotherapeutic in Antiretroviral Therapy (ART)-Treated Subjects Infected With HIV (NCT00672191) | Argos Therapeutics | 2008-02-01 |
| Pharmacokinetics of the Tablet Formulation of Lopinavir/r as Standard and Increased Dosage During Pregnancy (NCT00605098) | Oswaldo Cruz Foundation | 2008-02-01 |
| Safety of and Immune Response to an Adenoviral HIV-1 Vaccine in Healthy Adults (NCT00618605) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-02-01 |
| Adherence Intervention for People With Low-literacy (NCT01061762) | University of Connecticut | 2008-02-01 |
| Pharmacokinetics of Raltegravir During Third Trimester Pregnancy and Post-Partum (NCT00689910) | University of California, San Francisco | 2008-02-01 |
| HIV Non Occupational Post-Exposure Prophylaxis (PEP) (NCT00594646) | Fenway Community Health | 2008-02-01 |
| Raltegravir vs. Lopinavir/Ritonavir, Both in Combination With Truvada, in HIV+ Treatment Naive Individuals (NCT00632970) | George Washington University | 2008-02-01 |
| Empiric Therapy of Helminth Co-infection to Reduce HIV-1 Disease Progression (NCT00507221) | University of Washington | 2008-02-01 |
| Establishing Normal Values for Neuropsychological Testing in HIV-negative Thais (NCT00713752) | SEARCH Research Foundation | 2008-02-01 |
| Treatment of HIV/HCV Coinfection With Peg-IFN and Ribavirin in Patients Receiving ART Monotherapy With Lopinavir/r (NCT00866021) | Fundacion SEIMC-GESIDA | 2008-02-01 |
| Energy Specific Far Infrared Radiation Treatment for AIDS (NCT00574522) | GAAD Medical Research Institute Inc. | 2008-02-01 |
| Study of the Efficacy and Safety of Apricitabine, a New NRTI, to Treat Drug-resistant HIV Infection (NCT00612898) | Avexa | 2008-02-01 |
| Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women (NCT00604175) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-02-01 |
| Drug Interaction Between Coartem® and Nevirapine, Efavirenz or Rifampicin in HIV Positive Ugandan Patients (NCT00620438) | Makerere University | 2008-02-01 |
| Diagnosis of Tuberculosis Infection in HIV Co-infected Children (NCT00541294) | Case Western Reserve University | 2008-01-15 |
| INNOVE Study: A Study of 3 Months Induction With Fuzeon (Enfuvirtide) + Optimized Background (OB) Versus OB Alone in HIV-1 Infected Patients With Virological Failure. (NCT00615134) | Hoffmann-La Roche | 2008-01-01 |
| Immune Response to Toll-Like Receptor 9-Agonist Adjuvanted Pneumococcal Vaccination in HIV Infected Adults (NCT00562939) | University of Aarhus | 2008-01-01 |
| Safety and Effectiveness of Lopinavir/Ritonavir in Individuals Who Have Failed Prior HIV Therapy (NCT00357552) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2008-01-01 |
| Pharmacokinetics of Low Dose Ritonavir (NCT00622206) | The HIV Netherlands Australia Thailand Research Collaboration | 2008-01-01 |
| Evaluation of the Extension at Community Level of Safe Male Circumcision (ANRS 12126 ORANGE FARM 2) (NCT00623051) | French National Agency for Research on AIDS and Viral Hepatitis | 2008-01-01 |
| Positive Lifestyles Using Safety (NCT00836290) | Yale University | 2008-01-01 |
| HIV Screening in the Emergency Department Setting (NCT00667186) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-01-01 |
| Naïve HIV POC Monotherapy Trial (NCT00617526) | Ardea Biosciences, Inc. | 2008-01-01 |
| Postprandial Endothelial Dysfunction After a High-Fat Meal in HIV-infected Men (NCT00846599) | Tufts University | 2008-01-01 |
| Switching From PI to RALtegravir in HIV Stable Patients (NCT00528892) | Hospital Clinic of Barcelona | 2008-01-01 |
| Antiviral Activity of Peg-IFN-Alpha-2A in Chronic HIV-1 Infection (NCT00594880) | The Wistar Institute | 2008-01-01 |
| Optimizing Treatment for Treatment-Experienced, HIV-Infected People (NCT00537394) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-01-01 |
| Measure of Pharmacokinetic Parameters and Adherence With MEMS in Naive HIV Infected Patients Treated With Reyataz Once Daily Combined With Norvir and Truvada (NCT00528060) | French National Agency for Research on AIDS and Viral Hepatitis | 2008-01-01 |
| PRO 140 by IV Administration in Adults With HIV-1 Infection (NCT00613379) | CytoDyn, Inc. | 2007-12-01 |
| Neurocognitive Assessment in Youth Initiating HAART (NCT00683579) | University of North Carolina, Chapel Hill | 2007-12-01 |
| Conjugate And Polysaccharide Vaccines Compared With Polysaccharide Vaccine In Hiv-Infected Adults (NCT00999739) | Hospital Universitari Son Dureta | 2007-12-01 |
| A Rollover Study for Subjects Who Completed Participation in the VRX496-USA-05-002 Trial (NCT00622232) | VIRxSYS Corporation | 2007-12-01 |
| Clinical Sensitivity of Clearview Rapid Tests in 12-17 y/o Pediatric Population (NCT00567749) | Chembio Diagnostic Systems, Inc. | 2007-12-01 |
| Clinical Trial to Assess the Security of the Dose Reduction of Ritonavir in HIV-Infected Patients in Treatment With Tipranavir/Ritonavir 500/200 mg Every 12 Hours (NCT00607958) | Germans Trias i Pujol Hospital | 2007-12-01 |
| Reassessment of the Nutritional Status in Thai Orphans Living With HIV in a Family Style Community (NCT01002612) | Thai Red Cross AIDS Research Centre | 2007-12-01 |
| Vitamin D Reabsorption in Adolescents and Young Adults With HIV Infection (NCT00490412) | University of North Carolina, Chapel Hill | 2007-12-01 |
| Efficacy and Safety of VICRIVIROC in HIV-Infected Treatment-Naïve Subjects (Study P04875) (NCT00551018) | Merck Sharp & Dohme LLC | 2007-12-01 |
| Comparison of Nevirapine and Efavirenz for the Treatment of HIV-TB Co-infected Patients (ANRS 12146 CARINEMO) (NCT00495326) | French National Agency for Research on AIDS and Viral Hepatitis | 2007-12-01 |
| Lymphocyte Infusions for the Treatment of HIV-Infected Patients Failing Anti-HIV Therapy (NCT00559416) | National Institutes of Health Clinical Center (CC) | 2007-11-08 |
| A Phase I Pharmacokinetics and Safety Study of Two Dapivirine Intravaginal Gels (NCT00613249) | International Partnership for Microbicides, Inc. | 2007-11-01 |
| HIV-HBV Co-Infection and Liver Disease (NCT00637429) | Bayside Health | 2007-11-01 |
| Study of Niacin on Endothelial Function in HIV-infected Subjects With Low High Density Lipoprotein Cholesterol Levels (NCT00986986) | University of Hawaii | 2007-11-01 |
| The Role of Diet Education and Nutritional Counselling in the Ongoing Care of People Living With HIV in Thailand (NCT00549367) | Thai Red Cross AIDS Research Centre | 2007-11-01 |
| Evaluation of Cardiovascular Effects of Smoking Cessation in HIV Patients (NCT00918073) | The University of Texas Health Science Center, Houston | 2007-11-01 |
| Traditional CAM Therapy in the Treatment of HIV/AIDS (NCT00276991) | Traditional Alternative Medicine Research, India | 2007-11-01 |
| Antiretrovirals and Rate of Progression in Carotid Artery Intima-medial Thickness in HIV (NCT00575939) | University Hospitals Cleveland Medical Center | 2007-11-01 |
| Effect of Addition of Raltegravir (MK-0518) to PI- or NNRTI-Based ART Regimens in HIV Infected Subjects With Undetectable Viral Load (NCT00515827) | National Institute of Allergy and Infectious Diseases (NIAID) | 2007-11-01 |